T. Rowe Price Associates’s Aimmune Therapeutics AIMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,274,902	Closed	-$88.1M	–	2651
2020 Q2	$88.1M	Buy	5,274,902 +82,229	+2%	+$1.4M	0.01%	669
2020 Q1	$74.9M	Sell	5,192,673 -429,865	-8%	-$11M	0.01%	658
2019 Q4	$188M	Buy	5,622,538 +310,054	+6%	+$8.67M	0.02%	493
2019 Q3	$111M	Buy	5,312,484 +65,880	+1%	+$1.34M	0.02%	606
2019 Q2	$109M	Buy	5,246,604 +535,072	+11%	+$11M	0.02%	623
2019 Q1	$105M	Sell	4,711,532 -60,377	-1%	-$1.42M	0.02%	626
2018 Q4	$114M	Buy	4,771,909 +86,452	+2%	+$2.24M	0.02%	571
2018 Q3	$128M	Buy	4,685,457 +31,516	+0.7%	+$891K	0.02%	604
2018 Q2	$125M	Buy	4,653,941 +161,864	+4%	+$4.95M	0.02%	598
2018 Q1	$143M	Buy	4,492,077 +1,977,910	+79%	+$69.6M	0.02%	552
2017 Q4	$95.1M	Buy	2,514,167 +1,136,368	+82%	+$36.7M	0.02%	664
2017 Q3	$34.2M	Sell	1,377,799 -18,600	-1%	-$401K	0.01%	1001
2017 Q2	$28.7M	Buy	1,396,399 +227,627	+19%	+$4.34M	0.01%	1036
2017 Q1	$25.4M	Buy	1,168,772 +82,621	+8%	+$1.69M	﹤0.01%	1060
2016 Q4	$22.2M	Sell	1,086,151 -76,379	-7%	-$1.56M	﹤0.01%	1104
2016 Q3	$17.4M	Buy	1,162,530 +558,432	+92%	+$7.54M	﹤0.01%	1182
2016 Q2	$6.54M	Buy	604,098 +115,700	+24%	+$1.57M	﹤0.01%	1360
2016 Q1	$6.62M	Sell	488,398 -2,050	-0.4%	-$32K	﹤0.01%	1343
2015 Q4	$9.05M	Buy	490,448 +48,810	+11%	+$903K	﹤0.01%	1306
2015 Q3	$11.2M	Buy	+441,638	New	+$10.3M	﹤0.01%	1287